Researchers at the University of Leeds have found that a drug commonly used to treat epilepsy could help clear the plaques in the brain associated with Alzheimer's disease.
The plaques are known to lead to the progressive death of nerve cells in the brain linked to many forms of dementia.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
Sodium valproate - which is marketed as the anti-seizure drug Epilim - has been shown by the research team to reactivate the body's own defences against a small protein called amyloid beta peptide, which is the main component of the brain plaques characteristic in Alzheimer's.
"The fact that we've been able to show that a well-established, safe and relatively inexpensive drug could help treat Alzheimer's is an extremely exciting development," said lead researcher Professor Tony Turner from the University's Faculty of Biological Sciences.
Alzheimer's disease is the most common form of dementia and has no cure.
Source: ANI
SK
Alzheimer's disease is the most common form of dementia and has no cure.
Source: ANI
SK
Brilliant Human Brain - Animation
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
Advertisement
 Know Your Nervous SystemThe Central nervous system consists of the brain, the spinal cord, and the body's nerve network. This complex system is based on one kind of cell the neurons. | Advertisement
|
Alzheimer’s Disease May Be Treated With Existing Antiviral Drugs
Alzheimer's disease can be treated with existing drugs, according to a new study.
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.